Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-018021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-10 | 2023-03-08 | SRPT | Rodino-Klapac Louise | CSO, Head of R, D | F - Tax | $153.19 | -912 | 70.2K | -1% | -$139.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-08 | F | D | 912 | $153.19 | 70,170 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022. |